Treatment with a novel lipid A analogue, FS-112, and partial hepatectomy causes submassive liver necrosis and impaired liver regeneration in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 5, 1996, Pages 471-477

  Maeda, T ^a   Ohnishi, H ^a   Hayashi, T ^a   Ishiki, Y ^a   Moriwaki, H ^a   Muto, Y ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Animal model; Fulminant hepatitis; Impaired liver regeneration; Submassive liver necrosis

Indexed keywords

BILIRUBIN; ENDOGENOUS COMPOUND; FS 112; LIPID A DERIVATIVE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEPATITIS; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LIVER NECROSIS; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029923909     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00293.x     Document Type: Article

References (23)

1. Trey C. The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age on survival. Can. Med. Assoc. J. 1972; 106: 525-7.
2. Asami O, Ihara I, Shimizu N et al. Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J. Biochem. 1991; 109: 8-13.
3. Kinoshita T, Hirao S, Matsumoto K, Nakamura T. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem. Biophys. Res. Commun. 1991; 177: 330-5.
4. Jonker AM, Dijkhuis FW, Kroese FGM, Hardonk MJ, Grond J. Immunopathology of acute galactosamine hepatitis in rats. Hepatology 1990; 11: 622-7.
5. Francavilla A, Azzarone A, Carrieri G et al. Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993; 17: 429-33.
6. Higgins GM, Anderson M. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 1931; 12: 186-202.
7. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976; 25: 234-48.
8. Ichihara A, Nakamura T, Tanaka K et al. Biochemical functions of adult rat hepatocytes in primary culture. Ann. N.Y. Acad. Sci. 1980; 349: 77-84.
9. Nakamura T, Tomita Y, Ichihara A. Density-dependent growth control of adult rat hepatocytes in primary culture. J. Biochem. 1983; 94: 1029-35.
10. Selden C, Johnstone R, Darby H et al. Human serum does contain a high molecular weight hepatocyte growth factor: Studies pre- and post-hepatic resection. Biochem. Biophys. Res. Commun. 1986; 139: 361-6.
11. Giges B, Denin HL, Sborov VM, Seligson D, Howard JM. Experimental hepatic coma. Surg. Gynecol. Obstet. 1953; 97: 763-8.
12. Van Leenhoff JW, Hickman R, Saunders SJ et al. Massive liver cell necrosis induced in the pig by carbon tetrachloride. S. Afr. Med. J. 1974; 48: 1201-4.
13. Francavilla A, Makowka L, Polimeno L et al. A novel model of fulminant hepatic failure in dogs with implications for transplantation research. Transplant. Proc. 1988; 20 (Suppl. 1): 713-15.
14. Blitzer BL, Waggoner JG, Jones EA et al. A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978; 74: 664-71.
15. Gratzner HG. Monoclonal antibody to 5-bromo- and 5′-iododeoxyuridine: A new reagent for the detection of DNA replication. Science 1982; 218: 474-6.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984; 133: 1710-15.
17. Masaki S, Koiwai O, Yoshida S. 10S DNA polymerase alpha of calf thymus shows a microheterogeneity in its large polypeptide component. J. Biol. Chem. 1982; 257: 7172-7.
18. Bravo R, Flank R, Blundell PA, Macdonald-Blavo H. Cyclin/PCNA is the auxilary protein of DNA polymerase-δ. Nature 1987; 326: 515-17.
19. Kahn D, Gavaler JS, Lai H et al. Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomy. Dig. Dis. Sci. 1990; 35: 6-11.
20. 3. Cancer Res. 1962; 22: 842-9.
21. Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: A study of proliferating cell nuclear antigen expression. Hepatology 1992; 15: 707-13.
22. Itoh H, Abo T, Sugawara S, Kanno A, Kumagai K. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J. Immunol. 1988; 141: 315-23.
23. Sato Y, Tsukada K, Iiai T et al. Activation of extrathymic T cells in the liver during liver regeneration following partial hepatectomy. Immunology 1993; 78: 86-91.